AstraZeneca rises after report on $10 bln bid for obesity drugmaker Rhythm

By Reuters News

** Shares of AstraZeneca AZN.L up 1.3% at 14,208p

** AstraZeneca made an offer of about $10 billion for obesity drugmaker Rhythm RYTM.O, Reuters reported, citing people familiar with the matter

** AZN offered as much as $134 a share in the non-binding proposal, including payments for milestone achievements, the report said

** Stock has risen about 3% YTD

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk